Document ID: chunk:federal_register_of_legislation:F2024C00672:reg:5:p2
Version: federal_register_of_legislation:F2024C00672
Segment Type: reg
Provision Reference: reg 5 (pt 2/3)
Character Range: 6162–9022

benefit, a label that displays the following:
 (i) for a benefit other than an extemporaneously‑prepared pharmaceutical benefit or a benefit that is to be supplied in accordance with the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024—the brand of the pharmaceutical item in the benefit;
 (ii) if paragraph 40(2A)(b) or 41(2A)(b) of the Regulations applied to the prescription or continued dispensing prescription for the supply of the benefit—each drug that the benefit has;
 (iii) the form (if any) and quantity or number of units of the benefit;
 (iv) directions for use of the benefit in accordance with the instructions of the PBS prescriber who wrote the prescription or continued dispensing prescription for the supply of the benefit;
 (v) the name of the person for whom the prescription or continued dispensing prescription for the supply of the benefit was written;
 (vi) the date the benefit is dispensed;
 (vii) the address of the premises at which the benefit is dispensed;
 (viii) the name of the pharmacy situated at those premises (the dispensing pharmacy);
 (ix) if subsection 64(1) of the Regulations applies to the benefit—the full cost of the benefit;
 (d) if required by section 52 of the Regulations—preparing a repeat authorisation for the benefit;
 (e) recording the dispensing of the benefit in the dispensing pharmacy's system for recording the dispensing of pharmaceutical benefits.
Note 1: For paragraph (a), a prescription may be in the form of a paper‑based prescription or an electronic prescription (see section 39 of the Regulations).
Note 2: For subparagraphs (c)(ii), (iv) and (v), a prescription may be in the form of a paper‑based prescription, an electronic prescription or a medication chart prescription (see section 39 of the Regulations).
Note 3: For subparagraph (c)(iii), the form of a pharmaceutical benefit may be determined by reference to strength, type of unit, size of unit or otherwise, and may be such as to require the addition of a substance or substances to the drug so that it will be suitable for administration in a particular manner or at a particular strength (see subsections 85(3) and (4) of the Act).
       electronic prescription has the same meaning as in the Regulations.
       extemporaneously‑prepared pharmaceutical benefit has the same meaning as in the National Health (Listing of Pharmaceutical Benefits) Instrument 2024.
       listed brand has the same meaning as in Part VII of the Act.
 medication chart prescription has the same meaning as in the Regulations.
       pack quantity has the same meaning as in Part VII of the Act.
       paper‑based prescription has the same meaning as in the Regulations.
       PBS prescriber has the same meaning as in Part VII of the Act.
       pharmaceutical benefit has the same meaning as in Part VII of the Act.